Last update 23 Jan 2025

Suzhou Angtuo Biopharmaceutical Co., Ltd.

Private Company|
2023|
Jiangsu Sheng, China

Overview

Tags

Cardiovascular Diseases
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
Chemical drugs1

Related

1
Drugs associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
ART-101(Suzhou Angtuo)
Target-
Mechanism-
Active Org.
Suzhou Angtuo Biopharmaceutical Co., Ltd. [+1]
Originator Org.
Suzhou Angtuo Biopharmaceutical Co., Ltd.
Active Indication
Hypertension
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
CTR20250041
/ Not yet recruitingPhase 1
一项评价ART101注射液单次皮下注射给药在健康成年受试者中的安全性、耐受性、药代动力学及药效学特征的随机、双盲、安慰剂对照、剂量递增的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous injection of ART101 injection in healthy adult subjects
100 Clinical Results associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Angtuo Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ART-101(Suzhou Angtuo)
Hypertension
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free